Budapest, Hungary

Laszlo Tvos


Average Co-Inventor Count = 11.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1983-1990

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlo Tvos

Introduction

Laszlo Tvos is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of herpes infections. With a total of 5 patents to his name, Tvos has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Among his latest patents is a method of treating herpes eye infections using an ophthalmic composition that comprises 5-propyl-2'-deoxyuridine. This invention aims to provide an effective treatment for patients suffering from this condition. Another notable patent is a topical process for treating herpes infections, which involves an externally applicable antiviral pharmaceutical composition. This composition contains 0.2-5% by mass of 5-isopropyl-2'-.beta.-deoxyuridine, combined with carriers, diluents, and other additives commonly used in pharmaceutical formulations.

Career Highlights

Throughout his career, Tvos has worked with several prominent companies in the pharmaceutical industry. Notable among these are Egyt Gyogyszervegyeszeti Gyar and Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. His work in these organizations has contributed to the development of innovative treatments and has solidified his reputation as a skilled inventor.

Collaborations

Tvos has collaborated with several professionals in his field, including Anna Szabolcs Nee Borbas and Janos Sagi. These collaborations have likely enriched his work and contributed to the success of his inventions.

Conclusion

Laszlo Tvos is a distinguished inventor whose work has significantly impacted the treatment of herpes infections. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…